Regional News

NetEase to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24

HANGZHOU, China, Feb. 8, 2022 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), one ofChina's leading internet and online game services providers, today announced that it will report financial results for the fourth quarter and fiscal year 2021 on Thursday, ...

2022-02-08 16:30 3478

National Museum of Modern Art, Tokyo Launches "Let's Talk Art! Online," Conversational Program in English, from February 2022

TOKYO, Feb. 8, 2022 /PRNewswire/ -- The National Museum of Modern Art, Tokyo (MOMAT) inJapan launched "Let's Talk Art! Online," an online conversational program in English, onFebruary 2, 2022. Applications are accepted through Viator. Unlike guided tours where people only listen to explanations ...

2022-02-08 14:00 2158

Bijoyesh Mookerjee, M.D. named Chief Medical Officer, Oncology for Simcere Pharmaceuticals

NANJING, China, Feb. 7, 2022 /PRNewswire/ -- Simcere is thrilled to announce Bijoyesh Mookerjee, M.D., as our Chief Medical Officer, Oncology, of Simcere Pharmaceutical Group. Bijoyesh will be responsible for Simcere's oncology clinical pipeline strategy and development, enhancing our global res...

2022-02-08 10:01 2630

LG Energy Solution Announces Fourth Quarter and FY 2021 Results

* Reports quarterly revenue of KRW 4.44 trillion, 10.2 percent higher than previous quarter; operating profit atKRW 76 billion * Targets revenue goal of KRW19.2 trillion with plans to spend KRW 6.3 trillion in capital expenditures for 2022 SEOUL, South Korea, Feb. 7, 2022 /PRNewswire/ -- LG E...

2022-02-08 09:10 3053

Sedgwick University expands world-class training to Australia

SYDNEY, Feb. 8, 2022 /PRNewswire/ -- Sedgwick, a leading global provider of technology-enabled risk, benefits and integrated business solutions, will begin offering its acclaimed Sedgwick University training programs inAustralia to develop, upskill, and attract the next generation of claims profe...

2022-02-08 07:30 2923

Bridge Biotherapeutics and Scripps Research Launch Research Collaboration to Develop Discovery Platform and Novel Covalent Probes Based on Chemical Biology and Chemoproteomics

* Two-year research collaboration to develop new reactive group chemistries targeting non-cysteine amino acids to expand druggable binding sites and identify novel targets in oncology and immunology * Collaborators at Scripps are pioneers in the field of chemical biology and chemistry SEONGNA...

2022-02-08 06:00 2531

Novari Health Launches Surgical Overdues Management HUB Technology in Response to COVID-19 Crisis

SYDNEY, Feb. 8, 2022 /PRNewswire/ -- As the global pandemic continues to strain access to elective surgery, Novari Health has launched new technology to help manage COVID-19 surgical waiting lists inAustralia and New Zealand. For the first time ever, healthcare systems now have access to an innov...

2022-02-08 04:00 2755

Novari Health Launches Surgical Waiting List Management HUB Technology in Response to COVID-19 Crisis

AUCKLAND, New Zealand, Feb. 8, 2022 /PRNewswire/ -- As the global pandemic continues to strain access to elective surgery, Novari Health has launched new technology to help manage surgical waiting lists inNew Zealand and Australia. For the first time ever, healthcare systems now have access to an...

2022-02-08 03:00 2544

IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research

MELBOURNE, Australia, Feb. 7, 2022 /PRNewswire/ -- Premium manufacturer of chromatography for proteomics applications, IonOpticks, has entered an OEM partnership with the Bruker Corporation (Nasdaq: BRKR), allowing Bruker to expand their portfolio of 4D-Proteomics solutions with the release of th...

2022-02-08 00:01 2762

eMemory Partners with Intel Foundry Services to Boost Security in Leading-Edge Chips

HSINCHU, Taiwan, Feb. 7, 2022 /PRNewswire/ -- eMemory Technology Inc., Asia's largest provider of semiconductor intellectual property (IP), today announced it is joining Intel Foundry Services (IFS) Accelerator – IP Alliance. The collaboration will provide the leading-edge security solutions for ...

2022-02-08 00:00 3238

US FDA Study May Proceed letter for Clarity's Cu-64 SAR-bisPSMA trial in prostate cancer

SYDNEY, Feb. 7, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that it has received a confirmation from the US Food and Drug Adm...

2022-02-07 22:08 2936

Pop Culture Group Announces Joint Venture to Create a First-ever Street Dance Chain SaaS Platform in China

New joint venture will accelerate the development of dance organizations in China XIAMEN, China, Feb. 7, 2022 /PRNewswire/ – Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-pop culture company inChina, announced today that a strategic partnership with an investo...

2022-02-07 22:00 2937

KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE

SYDNEY, Feb. 7, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, DrJames Garner, will be presenting at the BIO CEO Conference, to be held in person and virtually inNew York, NY, from 14-17 Febr...

2022-02-07 21:00 4050

Origin Agritech Issues 2022 Guidance of 300% Revenue Growth

BEIJING, Feb. 7, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that it expects revenues to grow in excess of 300%, to over150 million RMB, and expects to turn a profit for fiscal 2022. The expected revenue ...

2022-02-07 20:00 3905

Samsung Biologics receives 2022 CMO Leadership Award in all six categories

INCHEON, South Korea, Feb. 7, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), announced that it has been selected as a winner of the 2022 CMO Leadership Awards presented by Outsourced Pharma and Life Science ...

2022-02-07 20:00 3059

NaaS raises RMB500 million Series A financing

BEIJING, Feb. 7, 2022 /PRNewswire/ -- NaaS, one of China's leading new energy operations and technology providers, today announced that it has successfully raisedRMB500 million in Series A financing from Real Fund, CICC Capital, GSR United Capital, and Sino Pacific Capital. About NaaS Establish...

2022-02-07 17:15 2494

Westwin (formerly Microsoft Online) launches new simplified Social Media solution for WeChat and Weibo

SHANGHAI, Feb. 7, 2022 /PRNewswire/ -- Westwin are proud to announce the launch ofwww.Wreach.net , which enables western companies to easily setup on WeChat and Weibo, then reuse their English content (translated, localised and proofread) onChina's biggest social media ...

2022-02-07 16:22 2918

Sohu.com to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 22, 2022

BEIJING, Feb. 7, 2022 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), China's leading online media, video and game business group, will report its fourth quarter and fiscal year 2021 unaudited financial results onTuesday, February 22 , 2022, before U.S. market hours. Sohu's management team wil...

2022-02-07 13:00 4192

Laekna Launched the new domain name www.laekna.com

SHANGHAI and WARREN, N.J., Feb. 6, 2022 /PRNewswire/ -- Laekna Group (Laekna Inc and all its direct or indirect subsidiaries, including Laekna Therapeutics Shanghai Co., Ltd.), an emerging innovative biotech based inChina's "Zhangjiang Pharma Valley" andNew Jersey in the U.S. and focused on devel...

2022-02-07 12:47 2042

Haitong International included in FTSE4Good Index Series

HONG KONG, Feb. 6, 2022 /PRNewswire/ -- Haitong International Securities Group Limited ("Haitong International" or "The Group"; Stock Code: 665.HK) announced today that the Group has been included in the FTSE4Good Index by global index provider FTSE Russell, which is owned by the London Stock Exc...

2022-02-07 12:36 3397